Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence-Reference-Cited by-同舟云学术

Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence

Published:2022-12 Issue: Volume:Volume 15 Page:7271-7292
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

de la Rosa-Carrillo David^ORCID,Suárez-Cuartín Guillermo,Golpe Rafael^ORCID,Máiz Carro Luis,Martinez-Garcia Miguel Angel^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference94 articles.

1. Consenso español para la prevención y el tratamiento de la infección bronquial por Pseudomonas aeruginosa en el paciente con fibrosis quística

2. Normativa sobre el tratamiento de las bronquiectasias en el adulto

3. European Respiratory Society guidelines for the management of adult bronchiectasis

4. Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The preventive effect of inhaled antibiotic against ventilator-associated pneumonia: a systematic review and meta-analysis;International Journal of Antimicrobial Agents;2024-09

2. Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection;International Journal of Pharmaceutics;2024-03

3. The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa;PLOS ONE;2023-10-12

4. Bronchiectasis: From targets to therapies;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-07-04

5. Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis;Pharmaceutics;2023-05-13